EUVIMEDSkopri EUVIMED
Crossref

Calpain‐2 as a therapeutic target for sodium danshensu in mitigating myocardial ischaemia–reperfusion injury

Xiaolu Zhang iD, Yujia Zheng iD, Baolei Dou iD, Qing Gao iD, Lin Yang iD, Miao Zeng iD, Guanwei Fan iD, Jiali Gan iD, Xijuan Jiang iD

British Journal of Pharmacology · 2026-12 · 183 (23) · 6847-6864

DOI: 10.1111/bph.70644 ↗

At a glance

Journal article in British Journal of Pharmacology, published online on 2026-08-19. Written by Xiaolu Zhang and 8 co-authors. Institution: First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China. Major MEDLINE topics: Myocardial Reperfusion Injury, Lactates, Calpain, Cardiotonic Agents. 40 references. Funded by: China Postdoctoral Science Foundation, Fellowship of China National Postdoctoral Program for Innovative Talents, National Natural Science Foundation of China.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Background and Purpose Myocardial reperfusion, a life‐saving intervention after heart attacks, paradoxically induces myocardial ischaemia–reperfusion injury (MIRI), a detrimental condition. MIRI is a persistent clinical challenge stemming from an incomplete understanding of its pathogenic mechanisms. This study aimed to identify the direct molecular target of sodium danshensu (SDSS) and elucidate the underlying mechanism by which it attenuates MIRI. Experimental Approach We integrated in vivo (left anterior descending artery ligation and reperfusion model) and in vitro (hypoxia‐reoxygenation model) approaches with proteomic profiling (HuProt™ microarray and liquid chromatography‐tandem mass spectrometry [LC–MS/MS]), biophysical validation (cellular thermal shift assay [CETSA] and drug affinity responsive target stability [DARTS]) and molecular docking. The functional role of the identified target, calpain‐2 (CAPN2) was further confirmed through pharmacological inhibition and genetic overexpression experiments. Key Results SDSS administration significantly attenuated MIRI in in vivo and in vitro models. Using direct target‐related technologies, CAPN2 was identified as a direct binding target of SDSS and was shown to be highly expressed in the heart. According to pathway enrichment analysis, CAPN2‐mediated apoptosis in cardiomyocytes was a primary mechanism by which SDSS alleviated MIRI. The cardioprotective effects of SDSS were replicated by a selective CAPN2 inhibitor and abolished upon CAPN2 overexpression. Conclusions and Implications SDSS confers cardioprotection by directly targeting and inhibiting CAPN2. This establishes CAPN2 as a potential therapeutic target for MIRI and provides a mechanistic basis for the development of SDSS‐based therapies.

Subjects

MeSH terms (MEDLINE)

Myocardial Reperfusion InjuryLactatesCalpainCardiotonic AgentsAnimalsMaleMolecular Docking SimulationApoptosisRats, Sprague-DawleyMyocytes, CardiacHumans

Author keywords

calpain‐2intrinsic apoptosismolecular targeted therapymyocardial ischaemia–reperfusion injurysodium danshensu

Substances

3,4-dihydroxyphenyllactic acidLactatesCalpainCardiotonic Agents

Authors and institutions

  • First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China.
  • National Clinical Research Center for Chinese Medicine, Tianjin, China.
  • Tianjin University of Traditional Chinese Medicine, Tianjin, China.

ORCID profiles: Xiaolu Zhang, Yujia Zheng, Baolei Dou, Qing Gao, Lin Yang, Miao Zeng, Guanwei Fan, Jiali Gan, Xijuan Jiang

Funding

  • China Postdoctoral Science Foundation
  • Fellowship of China National Postdoctoral Program for Innovative Talents
  • National Natural Science Foundation of China
  • Key Projects of Natural Science Foundation of Tianjin, China
  • Project of Tianjin Municipal Health Commission, China
  • Tianjin Municipal Education Commission

Cite

APA

Zhang, X., Zheng, Y., Dou, B., Gao, Q., Yang, L., Zeng, M., Fan, G., Gan, J., & Jiang, X. (2026). Calpain‐2 as a therapeutic target for sodium danshensu in mitigating myocardial ischaemia–reperfusion injury. British Journal of Pharmacology, 183(23), 6847-6864. https://doi.org/10.1111/bph.70644

Vancouver

Zhang X, Zheng Y, Dou B, Gao Q, Yang L, Zeng M, et al. Calpain‐2 as a therapeutic target for sodium danshensu in mitigating myocardial ischaemia–reperfusion injury. British Journal of Pharmacology. 2026;183(23):6847-6864. doi:10.1111/bph.70644

BibTeX
@article{Zhang2026,
  author = {Zhang, Xiaolu and Zheng, Yujia and Dou, Baolei and Gao, Qing and Yang, Lin and Zeng, Miao and Fan, Guanwei and Gan, Jiali and Jiang, Xijuan},
  title = {Calpain‐2 as a therapeutic target for sodium danshensu in mitigating myocardial ischaemia–reperfusion injury},
  journal = {British Journal of Pharmacology},
  year = {2026},
  volume = {183},
  number = {23},
  pages = {6847--6864},
  doi = {10.1111/bph.70644}
}
Start for free →